Document Detail


The initial clinical experience with an implantable cardioverter defibrillator/antitachycardia pacemaker.
MedLine Citation:
PMID:  1715549     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Guardian antitachycardia pacing (ATP) 4210 is a third generation, multi-programmable cardioverter defibrillator undergoing Phase I clinical trials. The tiered response includes ATP, low energy cardioversion or defibrillation, and bradycardia support. Extensive telemetry is available, including an episode log and details of all episode events. Five patients underwent the implantation of Guardian ATP 4210 as part of a Phase I trial at the University of Louisville. Two of the five patients had multiple VT episodes that were reverted successfully using ATP pacing (slow VT) and defibrillation (fast VT) and VF episodes, which resulted in defibrillation therapy over a follow-up period of 6 to 8 months. Four of the five patients required bradycardia support for bradyarrhythmias unassociated with ATP therapy or defibrillation and one patient required bradycardia support postdefibrillation therapy. The device design is microprocessor based and requires continuous interrogation of the microprocessor memory and checks of the validity of programmed parameters to continue its operation. When the safety check fails, the device is designed to shut down its antitachycardia and defibrillator functions. This design feature has a potential for leaving the patient unprotected if the device shuts down. Modification of this feature is required to ensure the device's long-term safety.
Authors:
I Singer; E Austin; W Nash; J Gilbo; J Kupersmith
Related Documents :
8031209 - The value of tilt table testing with isoproterenol in determining therapy in adults wit...
1697949 - Long-term antitachycardia pacing experience for supraventricular tachycardia.
902669 - Cough syncope: the possible relation to hydrocephalus ex vacuo.
10159769 - Left cardiac sympathetic denervation in long qt syndrome patients.
3916799 - Pathophysiology and management of atrial and ventricular arrhythmias in the critically ...
22564789 - Clinical pathways in acute pancreatitis: recommendations for early multidisciplinary ma...
19855439 - Management of relapse after allo-sct for aml and the role of second transplantation.
2041949 - Leptotrichia buccalis bacteremia in patients with cancer: report of four cases and review.
17595929 - Assessments for measuring patient-centered cultural sensitivity in community-based prim...
Publication Detail:
Type:  Clinical Trial; Journal Article    
Journal Detail:
Title:  Pacing and clinical electrophysiology : PACE     Volume:  14     ISSN:  0147-8389     ISO Abbreviation:  Pacing Clin Electrophysiol     Publication Date:  1991 Jul 
Date Detail:
Created Date:  1991-10-02     Completed Date:  1991-10-02     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  7803944     Medline TA:  Pacing Clin Electrophysiol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  1119-28     Citation Subset:  IM    
Affiliation:
Cardiovascular Division, University of Louisville, Kentucky 40292.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aged
Electric Countershock / instrumentation*
Electrocardiography
Female
Follow-Up Studies
Heart Ventricles
Humans
Male
Middle Aged
Pacemaker, Artificial*
Prostheses and Implants*
Tachycardia / physiopathology,  therapy*
Ventricular Fibrillation / therapy
Comments/Corrections
Comment In:
Pacing Clin Electrophysiol. 1991 Oct;14(10):1554-5   [PMID:  1721138 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Complete atrioventricular block following mediastinal irradiation: a report of six cases.
Next Document:  Clinical electrophysiological effects of intravenous recainam: an antiarrhythmic drug under investig...